Alcami Boosts Pharma Storage with Exciting Upgrades!

BIOT

featured image of Alcami Boosts Pharma Storage with Exciting Upgrades!
📦 Alcami has expanded its North Carolina pharma storage facility.

🌡️ The 65,000 ft² site now includes cold, stability, and custom storage options for temperature-sensitive products.

🧪 It offers materials management, aliquoting, and various temperature conditions.

🌎 This facility increases Alcami’s GMP storage locations across the U.S., addressing growing demands in biopharma.

🚀 It supports the development and commercialization of complex medicines.

📢 Alcami’s New Pharma Storage: Game Changer for Biopharma!

Introduction:

Alcami, a contract development and manufacturing organization (CDMO), recently announced the expansion of its pharmaceutical storage capabilities at its new facility in Garner, North Carolina. This development aims to address the increasing market demand for specialized storage conditions required for temperature-sensitive biopharma products.

Main points:

  1. The newly opened 65,000 ft2 facility offers diverse storage options for vaccines, biopharmaceuticals, and materials that require stringent temperature control.
  2. The facility has expanded its capabilities to include controlled, refrigerated, freezer, ultra-low freezer, and cryogenic storage.
  3. Alcami’s president emphasizes the facility’s strategic placement to serve the growing pipeline of complex medicines being developed in the Research Triangle area.
  4. The site provides comprehensive materials management services to support product development and commercialization.
  5. This expansion marks an increase in Alcami’s GMP storage network, now covering six locations across the U.S.

Conclusion:

Alcami’s enhancement of its North Carolina pharma storage facility not only addresses the burgeoning demand for specialized biopharma storage solutions but also expands its service offerings, thus positioning the company to play a crucial role in the development and commercialization of groundbreaking medical therapies. The future will likely see continued growth in this sector as the demand for complex medicinal products persists.

Leave a Comment